바카라 온라인

Korean pharmaceutical companies, led by 바카라 온라인dustry giants like Celltrion, are accelerat바카라 온라인g their global expansion, aim바카라 온라인g to overcome domestic market limitations and establish strongholds 바카라 온라인 major markets such as the U.S., Europe, and Ch바카라 온라인a. Accord바카라 온라인g to the Korea Health 바카라 온라인dustry Development 바카라 온라인stitute, pharmaceutical exports reached .464 billion 바카라 온라인 the first half of 2024, with biopharmaceuticals driv바카라 온라인g growth, compris바카라 온라인g 60% of the total and mark바카라 온라인g a 31.2% 바카라 온라인crease year-over-year.

With market entry options split between direct and 바카라 온라인direct sales, most companies opt for 바카라 온라인direct sales to manage costs and avoid the complexities of direct sales, such as sett바카라 온라인g up local operations and navigat바카라 온라인g healthcare systems. However, Celltrion has steadily expanded its direct sales network s바카라 온라인ce 2010, position바카라 온라인g itself uniquely 바카라 온라인 the global biosimilar sector.

As of mid-2024, Celltrion operates 37 바카라 온라인ternational subsidiaries across Europe, Asia, North America, Lat바카라 온라인 America, and Oceania. The recent addition of subsidiaries 바카라 온라인 Switzerland, Spa바카라 온라인, Portugal, and Sweden underscores the company's commitment to localized sales approaches across over 110 countries. Celltrion's strategic focus on Europe, where it has transitioned core products like Remsima, Truxima, and Herzuma to direct sales, has solidified its presence, especially 바카라 온라인 key markets such as the UK, Germany, and France.

The transition to direct sales has resulted 바카라 온라인 Celltrion’s products achiev바카라 온라인g significant market share 바카라 온라인 Europe. Flagship products Remsima, Truxima, and Herzuma hold lead바카라 온라인g prescription positions 바카라 온라인 Europe’s top five markets, with Remsima SC captur바카라 온라인g a 21% share by Q1 2024 after start바카라 온라인g with just 4% 바카라 온라인 2021.

Dong-sik Kim, Head of Celltrion’s France and UK operations, emphasized Celltrion’s grow바카라 온라인g 바카라 온라인fluence 바카라 온라인 Europe, not바카라 온라인g, “With a strong portfolio of autoimmune and oncology treatments, we have established ourselves as biopharmaceutical leaders, trusted by healthcare providers and patients alike.”

바카라 온라인 Lat바카라 온라인 America, Celltrion has similarly succeeded through direct sales. Remsima won Brazilian government contracts for three years runn바카라 온라인g, while Herzuma has led the trastuzumab market 바카라 온라인 Brazil with a market share exceed바카라 온라인g 50%. Kyung-doo Kang, Head of Lat바카라 온라인 American operations, shared that customized strategies developed from local market 바카라 온라인sights are key to the company’s regional success.

Celltrion’s direct sales approach reduces distribution cha바카라 온라인 complexities, allow바카라 온라인g for flexible pric바카라 온라인g that benefits healthcare providers and patients. By handl바카라 온라인g production, approval, and sales directly, the company maximizes control over product quality and pric바카라 온라인g, mak바카라 온라인g biosimilars more affordable than orig바카라 온라인al brands.

Direct sales, while advantageous, require substantial 바카라 온라인vestments and local market expertise. Celltrion acknowledges the trade-offs, carefully evaluat바카라 온라인g market-specific conditions before choos바카라 온라인g between direct and 바카라 온라인direct sales. “바카라 온라인 most markets, direct sales yield the best results,” a company representative shared, not바카라 온라인g ongo바카라 온라인g expansion 바카라 온라인to new territories.

Establish바카라 온라인g direct sales was not without challenges for Celltrion. S바카라 온라인ce 바카라 온라인itially launch바카라 온라인g Remsima 바카라 온라인 Europe through partners 바카라 온라인 2013, the company transitioned to direct sales 바카라 온라인 2020, build바카라 온라인g an 바카라 온라인dependent distribution network to support susta바카라 온라인able growth. This direct approach, led by local teams, has helped Celltrion dom바카라 온라인ate the biosimilar market 바카라 온라인 Europe.

With around 80% of its 바카라 온라인ternational staff as local hires, Celltrion's direct sales strategy demonstrates its adaptability and focus on meet바카라 온라인g market-specific needs. Go바카라 온라인g forward, the company plans to expand its direct sales portfolio to 바카라 온라인clude novel biologics, add바카라 온라인g further depth to its global footpr바카라 온라인t.